Greenbrook Tms IncOTCQB:GBNHF
- LAST PRICE0.0090
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0090/ 100
- Ask / Lots0.0112/ 482
- Open / Previous Close0.0092 / 0.0090
- Day Range
- 52 Week Range
- Volume160
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Sep 6, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enstar Group Limited (Nasdaq -- ESGR), PetIQ, Inc. (Nasdaq -- PETQ), Greenbrook TMS, Inc. (OTC -- GBNHF), GSE Solutions, Inc. (Nasdaq -- GVP), from 3:48PM ET on Friday Sep 06, 2024 by Dow Jones
3:48PM ET on Friday Sep 06, 2024 by Dow Jones
Aug 27, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq -- TWKS), PetIQ, Inc. (Nasdaq -- PETQ), Greenbrook TMS, Inc. (OTC -- GBNHF), GSE Solutions, Inc. (Nasdaq -- GVP), from 1:01PM ET on Tuesday Aug 27, 2024 by Dow Jones
1:01PM ET on Tuesday Aug 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Greenbrook Tms Inc | 305.7K | 0.0x | --- |
Quantum Medical Transport Inc | 10.1K | 0.0x | -12.92% |
First Choice Healthcare Solutions Inc | 187.9K | 0.0x | --- |
Mid Atlantic Home Health Network Inc | 1.2K | 0.0x | --- |
Selectis Health Inc | 4.9M | -0.8x | --- |
Nutrition Management Services Co | 280.0 | 0.0x | --- |
Company Information
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray), non-invasive therapies for the treatment of Major Depressive Disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The Company operates a network of outpatient mental health service centers that specialize in treatment across the United States. It offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The Company owns and operates 130 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, and Michigan.
Contact Information
- Headquarters
- 890 Yonge St 7th FloorTORONTO, ON, Canada M4W 3P4
- Phone
- 416-322-9700
- Fax
- 416-322-9700
Executives
- Executive Chairman of the Board
- Sasha Cucuz
- President, Chief Executive Officer, Director
- Bill Leonard
- Chief Financial Officer
- Peter Willett
- Chief Operating Officer
- Andrew Crish
- Chief Medical Officer
- Geoffrey Grammer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $305.7K |
|---|---|
Revenue (TTM) | $75.2M |
Shares Outstanding | 34.0M |
Greenbrook Tms Inc does not pay a dividend. | |
Beta | 1.58 |
EPS | $-1.20 |
Book Value | $-2.29 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -49.60% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
